Stem Cell Headlines: Monday, 11/30

The Clinic: How to live longer - 11.30.09

• CNN.com today featured a live Webcast of The Clinic, looking at how science is making progress in the quest for immortality. Geneticist Aubrey de Grey, the Chief Scientific Officer of SENS Foundation, said that techniques such as stem cell therapy, gene therapy and tissue engineering could one day be used in combination to let humans live for hundreds of years.

 

Emergent Health Corp. (EMGE) Reports Further Progress - 11.30.09

• The Company introduced its new improved Vita-Stim(TM) Stem Cell Nutrition formulation this quarter and expects product acceptance. Developmental sales of this product were made this month for export to two countries in a test market of 1048 units.
• Emergent Health revenues up 90%

 

Mesoblast Limited (ASX:MSB) Chairman Brian Jamieson Address At Annual General Meeting - 11.30.09

• Mesoblast Limited (ASX:MSB)(PINK:MBLTY) Chairman Brian Jamieson Address At Annual General Meeting - In December 2004, Mesoblast Limited listed on the Australian Stock Exchange. Its vision was to become a world leader in novel therapeutic approaches for patients with bone and joint diseases, including adult stem cell therapy for bone fractures and spinal disease, and for regeneration of damaged joint cartilage and intervertebral discs.

 

Swiss apple could banish wrinkles - 11.30.09

• Swiss scientists, in a paper published in the Journal of Applied Sciences, noted "These apples must have especially long-living tissue stem cells. Could we profit from these stem cells? "What would be the effect of an extract of such long-living stem cells on the skin?"

 

New Stem Cell Technology Provides Rapid Healing from Complicated Bone Fractures - 11.30.09

• A novel technology involving use of stem cells, developed by Hebrew University of Jerusalem researchers, has been applied to provide better and rapid healing for patients suffering from complicated bone fractures.

 

CYTX, WX, CSKI are Top Healthcare Stocks - 11.30.09

• Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) added $0.41 or 7.96% over its previous day’s price and now trades at $5.56 on an unusual huge volume of 435K shares. The stock today also touched new 52 week high at $5.60. Cytori Therapeutics, Inc. develops, manufactures, and sells medical technologies to enable the practice of regenerative medicine. The Company’s commercial activities are focused on cosmetic and reconstructive surgery in Europe and Asia-Pacific, and stem and regenerative cell banking (cell preservation) in worldwide.

 

American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company - 11.30.09

• American Diversified Holdings Corporation (ADHC.PK) is a publicly traded holding company headquartered in Del Mar, California engaged in developing innovative technologies in the life science sector with the primary emphasis in the stem cell arena.

 

M.D. Anderson joins Stemline in leukemia drug trials - 11.30.09

• The University of Texas M.D. Anderson Cancer Center is participating in a clinical trial with Stemline Therapeutics Inc. to test a leukemia drug.

 

Fear of losing sight drives the desperate to Russia - 11.30.09

• Invented by the clinic's founder Ernst Muldashev in 1970, the engineered material is said to attract stem cells which transform into other cells, causing tissue to regenerate, the centre's website states. It also says Alloplant can be implanted without rejection, can regenerate tissue and stimulate the growth of blood and lymphatic vessels.

 

Stimulus awards nearly $274 million so far to scientists in Michigan - 11.30.09

• At the University of Michigan, the majority of the grants (266) are coming from the NIH and are going to research into stem cells, cancer treatment and prevention, the impact of endocrine disruptor chemicals on fetal development, kidney disease genetics, stress as a factor in childhood obesity, and many other areas on the frontiers of medical research.

 

New technique could revolutionize stem-cell transplants - 11.30.09

• Montreal researchers are taking part in what could become a breakthrough in stem cell transplants, by leading the first transplant of a mismatched donor.

 

StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke - 11.30.09

• StemCyte, Inc. concluded an exclusive license and commercialization agreement with Academia Sinica, the National Laboratory of Taiwan, for certain proprietary methods and Intellectual Property (IP) related to the treatment of Chronic Stroke with stem cells.

 

U.S. buzz gives Canadian biotechs hope - 11.30.09

• IPOs from Cumberland, Omeros and Talecris have emboldened Atlanta-based Alimera Sciences Inc. and stem cell company Aldagen Inc., of Durham, N.C., to consider the IPO market again in 2009.

 

Stem cell breakthrough could help premature babies - 11.30.09

• An international team headed by a University of Alberta researcher has used stem cells to heal and protect the lungs of newborn rats - research that could help premature babies with chronic lung disease.

 

Stem cell boob jobs now available in UK - 11.29.09

• A procedure that uses a person's own stem cells to carry out a breast augmentation is now available in the UK. Lucy Mead, a 23-year-old sales adviser from Middlesex, told the Daily Mail that she had the procedure to boost her breasts from their original size 34C

 

BioTime Reports 3Q 2009 Financial Results - 11.29.09

• BioTime, Inc. (BTIM) has reported financial results for the quarter ended September 30, and an update.

 

Stem cell banks low on ethnic contributions - 11.29.09

• Health officials say that Canada's stem cell and bone marrow banks need more donors from the country's ethnic communities.

 

Israeli stem cell co BiogenCell raises $1m - 11.29.09

• Sources inform ''Globes'' that stem cell start-up BiogenCell Ltd. has raised $1 million. The company was founded a year ago on the basis of research by CEO Dr. Yael Porat, formerly CTO of stem cell firm TheraVitae Company Ltd.

 

Stem Cells' Next Use: Fighting Extinction - 11.29.09

• Conservationists work constantly through habitat protection and other means to save these and other endangered species. And now they are adding a new technology to their list of possible solutions to extinction -- stem cells.